PeptidePedia The community reference

Contributions of MergeMorwenna

User contributions·17 logged edits·page 1 of 1

Contributions by MergeMorwenna, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 411 edits includes activity predating the current log.

  1. 08:34, 28 May 2026 (diff | hist) Peptide stability table 6,886 ±0 add the cross-link from the calculator to the unit-conversion article
  2. 15:43, 21 May 2026 (diff | hist) Guangzhou JEEP Biotechnology 15,452 ±0 attribute the documentation description to the purchaser reports it comes from
  3. 08:52, 16 Mar 2026 (diff | hist) Talk:Temperature excursion 1,655 +172 /* Should freezing be a separate article? */ reply
  4. 13:26, 10 Mar 2026 (diff | hist) Talk:Temperature excursion 811 +352 /* Should freezing be a separate article? */ new section
  5. 01:34, 11 Feb 2026 (diff | hist) Orforglipron 5,647 ±0 expand §Reported clinical findings
  6. 11:09, 14 Dec 2025 (diff | hist) Talk:Karl Fischer titration 1,307 +91 /* Merge proposal: Loss on drying into this article */ reply
  7. 13:22, 9 Dec 2025 (diff | hist) Talk:Karl Fischer titration 674 +159 /* Merge proposal: Loss on drying into this article */ new section
  8. 14:10, 3 Dec 2025 (diff | hist) Talk:Albumin binding half-life extension 674 +117 /* Should this be merged into the agonist article? */ new section
  9. 09:14, 8 Nov 2025 (diff | hist) Talk:Insulin syringe unit conversion 1,307 +72 /* Merge proposal: into Insulin syringe */ reply
  10. 14:19, 2 Nov 2025 (diff | hist) Talk:Insulin syringe unit conversion 674 +150 /* Merge proposal: into Insulin syringe */ new section
  11. 08:24, 31 May 2025 (diff | hist) Electrospray ionisation 4,073 +561 add the forced-degradation conditions the claim rests on
  12. 08:33, 24 Mar 2025 (diff | hist) Talk:Vial 1,244 +205 /* Merge proposal: Multi-dose vial into this article */ reply
  13. 10:52, 18 Mar 2025 (diff | hist) Talk:Vial 400 +379 /* Merge proposal: Multi-dose vial into this article */ new section
  14. 03:12, 24 Feb 2025 (diff | hist) Trial data comparison 2,835 +439 correct the column header — that column is volume
  15. 09:44, 3 Feb 2025 (diff | hist) Talk:Shanghai Wibson Biotechnology 822 +305 /* Notability: what a five-year registry history establishes */ reply
  16. 23:41, 18 Oct 2024 (diff | hist) CagriSema 1,661 +1,661 N create article — compound stub
  17. 07:12, 13 Aug 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 2,583 +263 state that the frequency category follows the labelling convention